|
|
Abstract Submission The International Narcotics Research Conference
2008
Charleston, South Carolina, U.S.A.
|
Deadline: May 1, 2008 As many active participants as
possible are welcome at INRC meetings. Abstracts should be provided
for poster presentations, as well as all oral presentations
including Symposia, Founder, and Plenary lectures. If you haven't
been invited to give an oral presentation, please plan on preparing
a poster. Some authors will be invited to give a short oral
presentation after submission of an abstract.
Posters: To accommodate all
posters on display for the duration of the meeting, poster boards
are 4' by 8' but will be shared by two posters. Thus the maximum
size for each poster presentation is 4 feet by 4 feet (height and width of 48 inches (120cm)
each). However as space is needed between the two posters sharing a
side, please use:
poster size: 44 inches high by
44 inches wide (110 cm by 110 cm)
Please bring your own push-pins to
mount your poster to the board.
You will find
your abstract number in the abstract book which you will obtain when
registering for the meeting in Charleston or earlier on the INRC
website.
Abstract Submission
Instructions
Abstracts may only be submitted
electronically for this meeting. Please note the abstract submission
deadline of May 1, 2008!
Please type up your abstract
according to this sample:
INVOLVEMENT OF GLT-1, A GLIAL GLUTAMATE
TRANSPORTER, IN PHYSICAL AND PSYCHOLOGICAL MORPHINE DEPENDENCE
T. Nakagawa (1), T. Ozawa (1), Y. Sekiya (1), H. Ueda (2), M.
Satoh (1) (1)Dept. of Mol. Pharmacol., Grad. Sch. of Pharmaceut.
Sci., Kyoto Univ., Kyoto, Japan, (2)Dept. of Mol. Pharmacol. and
Neurosci., Sch. of Pharmaceut. Sci.,Nagasaki Univ., Nagasaki,
Japan
We previously reported the changes in the
expression of the glial glutamate transporter GLT-1 mRNA in some
brain regions of morphine-dependent rats. In this study, we
examined the roles of GLT-1 in physical and psychological
dependence on morphine.........etc. DON'T FORGET to acknowledge
your funding source at end!!
Do NOT use Greek
symbols but spell out symbols as much as possible. Use character
count tools! Keep total characters (including titles, names,
institutions & spaces) to no more than 1400 characters.
Please indicate a maximum of 2
keywords in your email. The following symposia are planned and
additional short oral presentations will be chosen from submitted
abstracts.
1. Drug Seeking: Reconsolidation
and Disruption
2. Opioid Regulation of Reward System
3. Genetics and Genomics in Drug Addiction
4. Opioid Receptor Regulation and Signaling
5. Translational Studies in Depression and Opioids
6. Molecular Dysregulation in the dynorphin/KOR system: relevance
for the
“dark side of addiction”
7. In vivo opioid imaging
IMPORTANT! Please name your abstract word file with your last
name,
then initials of your other names.
(for example; stevenscw.doc)
Save your abstract document as a Microsoft word doc and attach it to an
email to one of the the following email addresses according to your
last name: A-L
to: mcginty@musc.edu
M-Z to: gomea@musc.edu
If your email program does not allow attachments, please paste text
of your abstract directly in the body of an email.
File type: Word.doc is preferred.
Font: Times or Times New Roman.
Size: No more than 1400 characters including titles, authors,
and spaces.
Please indicate in your email if you are willing to present an oral
presentation if selected.
Symposia, Founder, and Plenary lecturers abstracts can be
2800 characters at most.
Abstract Publication
Abstracts will be available for viewing at the INRC website and in
the abstract book distributed at the Meeting. |
|
Comments or suggestions can be emailed to
the INRC Information Officer at: cw.stevens@okstate.edu
This site supported by server space and
system administration generously
donated by OSU-Center
for Health Sciences, Tulsa, OK, U.S.A. |
